Hearing that uterine (endometrial) cancer has returned can feel overwhelming. Recurrence can be one of the hardest parts of a cancer diagnosis because it can bring back fear, uncertainty, and questions about what comes next. Advances in treatment, biomarker testing, and personalized care are creating more options and more hope than ever before. According to […]

Not all uterine (endometrial) cancer recurrences behave the same way and that difference can shape everything about your treatment path. The concept of recurrence tempo describes the time elapsed between completing primary treatment and the moment relapse appears. It’s more than a timeline detail. It’s a biological signal. Approximately 60% of uterine (endometrial) cancer recurrences […]

Finishing treatment for endometrial (uterine) cancer is a significant milestone, but staying vigilant afterward matters just as much. Cancer recurrence is a real concern for many survivors, with most recurrences happening within the first three years after treatment ends. That’s why a structured monitoring plan isn’t optional. It’s a core part of your care. Monitoring […]

Endometrial (uterine) cancer care is evolving. Beyond stage and grade, doctors are using molecular information to understand how a tumor behaves and how best to treat it. As treatment becomes more personalized, researchers are looking for better ways to monitor disease. One promising area of research is circulating tumor DNA (ctDNA). ctDNA consists of tiny […]

When facing uterine (endometrial) cancer, understanding your treatment options is key. Surgery, chemotherapy, radiation, or hormone therapy may be recommended depending on your stage. Clinical trials can provide additional opportunities for treatments tailored to your specific tumor profile. They can help patients access promising therapies while contributing to research that improves care for others. In […]